SCHEMBL6281131

SCHEMBL6281131

CN(CC(=O)c1cnccn1)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.52
NAPRT Q6XQN6 1/20 0.52
HCAR2 Q8TDS4 1/20 0.52
TSHR P16473 2/20 0.46
ADORA3 P0DMS8 1/20 0.46
MC4R P32245 1/20 0.46
ADRA1A P35348 1/20 0.46
MC3R P41968 1/20 0.46
POLB P06746 2/20 0.43
SMN1; SMN2 Q16637 4/20 0.42
RAB9A P51151 3/20 0.42
NPC1 O15118 2/20 0.42
MAPT P10636 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
ALDH1A1 P00352 2/20 0.40
USP2 O75604 1/20 0.39
GAA P10253 1/20 0.39
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20524453 0.77 LMNA (0.52) KDM4ENAPRTSMN1; SMN2RAB9ANPC1
SCHEMBL31703690 0.75 KDM4E (0.48) KDM4ENAPRTHCAR2TSHRADORA3
SCHEMBL2632671 0.74 KDM4E (0.58) KDM4ENAPRTHCAR2TSHRADORA3
SCHEMBL15658741 0.74 KDM4E (0.45) KDM4ENAPRTHCAR2TSHRADORA3
SCHEMBL1321794 0.73 KDM4E (0.61) KDM4ENAPRTHCAR2TSHRADORA3
SCHEMBL2568939 0.72 KDM4E (0.50) KDM4ENAPRTHCAR2TSHRADORA3
SCHEMBL19210477 0.72 TDP1 (0.44) KDM4ENAPRTHCAR2POLBRAB9A
SCHEMBL5907971 0.72 KDM4E (0.46) KDM4ENAPRTHCAR2TSHRADORA3
SCHEMBL15974626 0.72 PLOD2 (0.58) KDM4EHCAR2TSHRMAPTTDP1
Pyrazinoic Acid SCHEMBL27774819 0.72 KDM4E (0.95) KDM4ENAPRTHCAR2TSHRADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6878705-B2 4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamide antiviral agents PFIZER (US) 2005-04-12 US disclosed
US-20040259907-A1 4-OXO-4,7-DIHYDROFURO[2,3-B]PYRIDINE-5-CARBOXAMIDE ANTIVIRAL AGENTS PHARMACIA & UPJOHN COMPANY 2004-12-23 US disclosed
US-20040110787-A1 Heteroaryl-ethanolamine derivatives as antiviral agents PHARMACIA & UPJOHN COMPANY 2004-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259907-A1 4-OXO-4,7-DIHYDROFURO[2,3-B]PYRIDINE-5-CARBOXAMIDE ANTIVIRAL AGENTS IL4, ZC3HAV1, IRF3 KDM4E 42/4885NAPRT 1900/4885HCAR2 1427/4885
US-20040110787-A1 Heteroaryl-ethanolamine derivatives as antiviral agents RPL35, ZC3HAV1, RPL5 KDM4E 775/4885NAPRT 408/4885HCAR2 2213/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.